December 20, 2024

Small HCQ Study Falls to Retraction

When combining hydroxychloroquine with azithromycin, researchers reported 100% virological cure by day 6 compared to 57.1% with hydroxychloroquine alone and 12.5% in controls - though the now-retracted study's small sample included just 6 patients receiving both drugs.

Conexiant

December 20, 2024

New Arthritis Findings Span Two Decades

New research reveals increased risk factors for psoriatic arthritis in patients with juvenile idiopathic arthritis over an 18-year study period in the Nordic region.

Conexiant

December 20, 2024

Introducing the Quirky Clinic

Each week we’ll dive into the strangest and most surprising medical stories, from cutting-edge science to unbelievable true tales.

Conexiant

December 20, 2024

Long COVID Shows Five Distinct Patterns: Study

In the 2024 update, the NIH's RECOVER Initiative identified five distinct symptom patterns and new diagnostic thresholds for long COVID.

Conexiant

December 20, 2024

POI Guidelines See First Major Update Since 2015

Four medical societies have revised their diagnostic criteria for premature ovarian insufficiency, now requiring only one elevated FSH test instead of two, while reporting a higher than previously known prevalence rate of 3.5% among women.

Conexiant

December 19, 2024

Ancient DNA Still Affects Tooth Size Today

New research reveals that Neanderthal DNA variants in the HS3ST3A1 gene, which regulates tooth development and influences incisor width, persist in modern Europeans, providing the first molecular evidence linking archaic human genes to contemporary dental variation.

Conexiant

December 19, 2024

Plant-Based Meat Study Reveals Depression Link

A study on UK vegetarians and plant-based meat alternatives revealed surprising health outcomes related to depression, irritable bowel syndrome, and blood biochemistry levels.

Conexiant

December 19, 2024

FDA Redefines 'Healthy' Food Claims

The regulation requires qualifying foods to contain amounts from at least one food group or subgroup referenced in the Dietary Guidelines for Americans.

Conexiant

December 19, 2024

FDA Rejects New Bowel Disease Drug

The FDA declined to approve Zealand Pharma's bowel disease drug and sought an additional trial to confirm the drug's safety and efficacy, impacting thousands of adult patients in the United States.

Reuters